Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds

被引:97
作者
Wang, Yongyu [1 ]
Hu, Jiang [2 ]
Jiao, Jiao [1 ]
Liu, Zhongning [2 ]
Zhou, Zhou [1 ]
Zhao, Chao [2 ]
Chang, Lung-Ji [3 ]
Chen, Y. Eugene [1 ]
Ma, Peter X. [2 ,4 ,5 ,6 ]
Yang, Bo [1 ]
机构
[1] Univ Michigan, Ctr Cardiovasc, Dept Cardiac Surg, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA
[3] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
[4] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Ctr Macromol Sci & Engn, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA
关键词
Human induced pluripotent stem cell; Smooth muscle cell; Nanofibrous scaffold; Tissue-engineered vascular tissue; BLOOD-VESSELS; DIFFERENTIATE; CONSTRUCTION; THERAPY; GRAFTS; MARROW;
D O I
10.1016/j.biomaterials.2014.07.011
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
Tissue-engineered blood vessels (TEBVs) are promising in the replacement of diseased vascular tissues. However, it remains a great challenge to obtain a sufficient number of functional smooth muscle cells (SMCs) in a clinical setting to construct patient-specific TEBVs. In addition, it is critical to develop a scaffold to accommodate these cells and retain their functional phenotype for the regeneration of TEBVs. In this study, human induced pluripotent stem cells (iPSCs) were established from primary human aortic fibroblasts, and characterized with the pluripotency markers expression and cells' capabilities to differentiate into all three germ layer cells. A highly efficient method was then developed to induce these human iPSCs into proliferative SMCs. After multiple times of expansion, the expanded SMCs retained the potential to be induced into the functional contractile phenotype of mature SMCs, which was characterized by the contractile response to carbachol treatment, up-regulation of specific collagen genes under transforming growth factor beta 1 treatment, and up-regulation of specific matrix metalloproteinase genes under cytokine stimulation. We also developed an advanced macroporous and nanofibrous (NF) poly(L-lactic acid) (PLLA) scaffold with suitable pore size and interpore connectivity to seed these human iPSC-derived SMCs and maintain their differentiated phenotype. Subcutaneous implantation of the SMC-scaffold construct in nude mice demonstrated vascular tissue formation, with robust collagenous matrix deposition inside the scaffold and the maintenance of differentiated SMC phenotype. Taken together, this study established an exciting approach towards the construction of patient-specific TEBVs. We established patient-specific human iPSCs, derived proliferative SMCs for expansion, turned on their mature contractile SMC phenotype, and developed an advanced scaffold for these cells to regenerate vascular tissue in vivo. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8960 / 8969
页数:10
相关论文
共 24 条
[1]
Stem Cell Sources for Vascular Tissue Engineering and Regeneration [J].
Bajpai, Vivek K. ;
Andreadis, Stelios T. .
TISSUE ENGINEERING PART B-REVIEWS, 2012, 18 (05) :405-425
[2]
Chang L.-J., 2001, Current Gene Therapy, V1, P237, DOI 10.2174/1566523013348634
[3]
Readily Available Tissue-Engineered Vascular Grafts [J].
Dahl, Shannon L. M. ;
Kypson, Alan P. ;
Lawson, Jeffrey H. ;
Blum, Juliana L. ;
Strader, Justin T. ;
Li, Yuling ;
Manson, Roberto J. ;
Tente, William E. ;
DiBernardo, Louis ;
Hensley, M. Taylor ;
Carter, Riley ;
Williams, Tiare P. ;
Prichard, Heather L. ;
Dey, Margaret S. ;
Begelman, Keith G. ;
Niklason, Laura E. .
SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (68)
[4]
STROMAL CELLS FROM HUMAN LONG-TERM MARROW CULTURES ARE MESENCHYMAL CELLS THAT DIFFERENTIATE FOLLOWING A VASCULAR SMOOTH-MUSCLE DIFFERENTIATION PATHWAY [J].
GALMICHE, MC ;
KOTELIANSKY, VE ;
BRIERE, J ;
HERVE, P ;
CHARBORD, P .
BLOOD, 1993, 82 (01) :66-76
[5]
Improving small-diameter vascular grafts: From the application of an endothelial cell lining to the construction of a tissue-engineered blood vessel [J].
Heyligers, JMM ;
Arts, CHP ;
Verhagen, HJM ;
de Groot, PG ;
Moll, FL .
ANNALS OF VASCULAR SURGERY, 2005, 19 (03) :448-456
[6]
Retention of endothelial cell adherence to porcine-derived extracellular matrix after disinfection and sterilization [J].
Hodde, JP ;
Record, RD ;
Tullius, RS ;
Badylak, SF .
TISSUE ENGINEERING, 2002, 8 (02) :225-234
[7]
Construction of Vascular Tissues with Macro-Porous Nano-Fibrous Scaffolds and Smooth Muscle Cells Enriched from Differentiated Embryonic Stem Cells [J].
Hu, Jiang ;
Xie, Changqing ;
Ma, Haiyun ;
Yang, Bo ;
Ma, Peter X. ;
Chen, Y. Eugene .
PLOS ONE, 2012, 7 (04)
[8]
Porous nanofibrous PLLA scaffolds for vascular tissue engineering [J].
Hu, Jiang ;
Sun, Xuan ;
Ma, Haiyun ;
Xie, Changqing ;
Chen, Y. Eugene ;
Ma, Peter X. .
BIOMATERIALS, 2010, 31 (31) :7971-7977
[9]
Small-diameter artificial arteries engineered in vitro [J].
Isenberg, BC ;
Williams, C ;
Tranquillo, RT .
CIRCULATION RESEARCH, 2006, 98 (01) :25-35
[10]
Molecular regulation of vessel maturation [J].
Jain, RK .
NATURE MEDICINE, 2003, 9 (06) :685-693